OPHIDION, INC. is developing a new class of safe and effective drugs targeting some of the most important receptors in the central nervous system. It is targeting relief of the symptoms of schizophrenia, ADHD, Parkinson’s disease, and Alzheimer’s disease as well as addiction and anxiety. The founder launched the company in the Pasadena Bioscience Collaborative Continue Reading…
NEXTSHIFT INTERACTIVE provides digital marketing, innovative healthcare industry software and consulting services to large pharmaceutical, medical device, and healthcare industry clients. Its web-based and mobile-enabled analytic tools help its clients understand and communicate better with their customers.